GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 1 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $892,000 | -13.1% | 27,917 | -5.7% | 0.51% | +22.2% |
Q1 2022 | $1,026,000 | +16.1% | 29,615 | -1.9% | 0.42% | +33.4% |
Q4 2021 | $884,000 | -45.8% | 30,187 | -52.9% | 0.31% | -46.6% |
Q3 2021 | $1,632,000 | -34.0% | 64,051 | -9.2% | 0.58% | -33.2% |
Q2 2021 | $2,471,000 | -14.1% | 70,570 | -0.1% | 0.87% | -17.0% |
Q1 2021 | $2,878,000 | +3.3% | 70,637 | +9.8% | 1.05% | -2.0% |
Q4 2020 | $2,786,000 | -3.9% | 64,321 | +22.3% | 1.07% | -19.4% |
Q3 2020 | $2,900,000 | +7.1% | 52,597 | +22.6% | 1.33% | -3.4% |
Q2 2020 | $2,709,000 | +17.6% | 42,917 | -4.9% | 1.38% | -2.6% |
Q1 2020 | $2,304,000 | -36.3% | 45,105 | -0.9% | 1.41% | -15.2% |
Q4 2019 | $3,618,000 | +63.0% | 45,516 | -0.5% | 1.67% | +60.6% |
Q3 2019 | $2,219,000 | -5.9% | 45,726 | +2.1% | 1.04% | -5.7% |
Q2 2019 | $2,357,000 | -0.1% | 44,801 | +0.5% | 1.10% | -6.3% |
Q1 2019 | $2,360,000 | +28.3% | 44,584 | -0.5% | 1.18% | +10.7% |
Q4 2018 | $1,839,000 | +14.7% | 44,788 | +6.2% | 1.06% | +55.6% |
Q3 2018 | $1,603,000 | -12.5% | 42,183 | +4.1% | 0.68% | -16.3% |
Q2 2018 | $1,832,000 | -7.1% | 40,541 | -0.7% | 0.82% | -14.1% |
Q1 2018 | $1,971,000 | +2.5% | 40,816 | -16.5% | 0.95% | +16.2% |
Q4 2017 | $1,923,000 | +30.2% | 48,865 | +2.7% | 0.82% | +24.0% |
Q3 2017 | $1,477,000 | – | 47,565 | – | 0.66% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |